Over the past 12 months, 13 insiders at EXELIXIS, INC. filed 32 open-market SEC Form 4 transactions on EXEL: 1 purchase worth $1.2M and 31 sales worth $41.7M. Insiders have been net sellers over this period. The most recent filing was on Jun 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 26 | Sue Gail Eckhardt | SELL | 9.8K | $50.14 | $492K |
| Jun 1, 26 | Jack L Wyszomierski | SELL | 3.9K | $50.55 | $198K |
| May 26, 26 | Dana AftabEVP, Research and Development | SELL | 43.5K | $50.35 | $2.2M |
| May 20, 26 | Patrick J. HaleyEVP, Commercial | SELL | 32.1K | $49.81 | $1.6M |
| May 18, 26 | Brenda HeftiSVP and General Counsel | SELL | 6.6K | $50.21 | $333K |
| May 18, 26 | Christopher J. SennerEVP and CFO | SELL | 34.9K | $50.00 | $1.7M |
| May 7, 26 | Mary C Beckerle | SELL | 7.7K | $48.45 | $374K |
| May 7, 26 | Maria C Freire | SELL | 20.6K | $46.00 | $949K |
| May 7, 26 | George Poste | SELL | 60.0K | $45.71 | $2.7M |
| Feb 24, 26 | Dana AftabEVP, Research and Development | SELL | 47.9K | $44.50 | $2.1M |
| Feb 19, 26 | Dana AftabEVP, Research and Development | SELL | 29.9K | $44.35 | $1.3M |
| Feb 18, 26 | Jack L WyszomierskiDirector | SELL | 99.6K | $44.01 | $4.4M |
| Feb 18, 26 | Julie SmithDirector | SELL | 44.1K | $44.50 | $2.0M |
| Feb 18, 26 | Brenda HeftiSVP and General Counsel | SELL | 18.7K | $44.01 | $822K |
| Feb 17, 26 | Julie SmithDirector | SELL | 42.4K | $43.33 | $1.8M |
| Feb 17, 26 | Patrick J. HaleyEVP, Commercial | SELL | 64.8K | $43.84 | $2.8M |
| Feb 17, 26 | Christopher J. SennerEVP and CFO | SELL | 30.6K | $43.67 | $1.3M |
| Feb 13, 26 | Sue Gail EckhardtDirector | SELL | 3.9K | $43.79 | $169K |
| Feb 13, 26 | Bob OliverDirector | SELL | 21.2K | $43.90 | $929K |
| Feb 13, 26 | Christopher J. SennerEVP and CFO | SELL | 34.3K | $43.00 | $1.5M |
| Nov 25, 25 | Caligan Partners LpDirector,Other | BUY | 27.5K | $43.12 | $1.2M |
| Nov 21, 25 | Patrick J. HaleyEVP, Commercial | SELL | 28.0K | $42.58 | $1.2M |
| Nov 20, 25 | Patrick J. HaleyEVP, Commercial | SELL | 23.5K | $42.11 | $987K |
| Nov 12, 25 | Stelios PapadopoulosDirector | SELL | 100.0K | $43.55 | $4.4M |
| Nov 11, 25 | Dana AftabEVP, Research and Development | SELL | 48.4K | $42.50 | $2.1M |
| Nov 11, 25 | Mary C BeckerleDirector | SELL | 18.8K | $42.03 | $789K |
| Jun 3, 25 | Jack L WyszomierskiDirector | SELL | 7.5K | $43.09 | $325K |
| Jun 2, 25 | Sue Gail EckhardtDirector | SELL | 18.8K | $43.67 | $805K |
| May 21, 25 | Tomas J. HeymanDirector | SELL | 4.5K | $44.29 | $201K |
| May 20, 25 | Patrick J. HaleyEVP, Commercial | SELL | 34.4K | $44.06 | $1.5M |
| May 16, 25 | George PosteDirector | SELL | 20.6K | $45.99 | $949K |
| May 16, 25 | Amy C. PetersonEVP Prod Dev & Med Aff & CMO | SELL | 72.8K | $45.47 | $3.3M |
| May 16, 25 | Christopher J. SennerEVP and CFO | SELL | 100.0K | $46.00 | $4.6M |
| May 15, 25 | Jeffrey HessekielEVP & General Counsel | SELL | 25.0K | $46.18 | $1.2M |
| May 15, 25 | Stelios PapadopoulosDirector | SELL | 20.6K | $44.35 | $915K |
| May 15, 25 | Patrick J. HaleyEVP, Commercial | SELL | 116.4K | $48.05 | $5.6M |
| May 14, 25 | Patrick J. HaleyEVP, Commercial | SELL | 10.0K | $42.68 | $427K |
| May 1, 25 | Dana AftabCSO/EVP Disc & Trans Research | SELL | 1.5K | $39.00 | $59K |
| Mar 3, 25 | Patrick J. HaleyEVP, Commercial | SELL | 10.0K | $38.80 | $388K |
| Feb 28, 25 | Jack L WyszomierskiDirector | SELL | 8.8K | $37.80 | $331K |
| Feb 28, 25 | Julie SmithDirector | SELL | 19.3K | $37.62 | $726K |
| Feb 27, 25 | Julie SmithDirector | SELL | 54.5K | $38.13 | $2.1M |
| Feb 25, 25 | Bob OliverDirector | SELL | 18.6K | $37.25 | $695K |
| Feb 24, 25 | Dana AftabCSO/EVP Disc & Trans Research | SELL | 27.0K | $36.75 | $992K |
| Feb 24, 25 | Patrick J. HaleyEVP, Commercial | SELL | 52.6K | $36.98 | $1.9M |
| Feb 24, 25 | Christopher J. SennerEVP and CFO | SELL | 29.3K | $36.14 | $1.1M |
| Feb 14, 25 | Mary C BeckerleDirector | SELL | 8.4K | $34.90 | $291K |
| Feb 14, 25 | Sue Gail EckhardtDirector | SELL | 7.7K | $35.04 | $270K |
| Feb 14, 25 | Maria C FreireDirector | SELL | 44.1K | $34.94 | $1.5M |
| Feb 14, 25 | George PosteDirector | SELL | 15.9K | $34.74 | $551K |
Over the past 12 months, insiders at EXELIXIS, INC. filed 1 open-market purchase worth $1.2M and 31 sales worth $41.7M on EXEL, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 1, 26.
The largest recent open-market EXEL insider purchase in our data was $1.2M by Caligan Partners Lp, Director,Other, filed on Nov 25, 25.
13 different insiders at EXELIXIS, INC. filed open-market SEC Form 4 transactions on EXEL over the last 12 months.
InsiderTape plots every EXEL insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every EXELIXIS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →